REAL WORLD OUTCOMES IN PATIENTS WITH ADVANCED/METASTATIC SOLID TUMORS WHO ARE IMMUNO-ONCOLOGY (IO) NAIVE AND RECEIVED SECOND-LINE THERAPY: ANALYSIS BY TUMOR MUTATIONAL BURDEN (TMB) STATUS

被引：0

作者：

Gogate, A. ^{[1
]}

Palaia, J. ^{[2
]}

Zhang, Y. ^{[2
]}

You, M. ^{[2
]}

Sama, A. ^{[2
]}

机构：

[1] Bristol Myers Squibb, Pennington, NJ USA

[2] Bristol Myers Squibb, Lawrence Township, NJ USA

来源：

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

RWD110

引用

页码：S470 / S470

页数：1